Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Akso Health (AHG) Loans and Notes Receivables (2018 - 2022)

Akso Health (AHG) has disclosed Loans and Notes Receivables for 5 consecutive years, with $46.1 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Loans and Notes Receivables rose 740.29% year-over-year to $46.1 million, compared with a TTM value of $46.1 million through Mar 2022, up 740.29%, and an annual FY2022 reading of $46.1 million, up 740.29% over the prior year.
  • Loans and Notes Receivables was $46.1 million for Q1 2022 at Akso Health, up from $5.5 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $46.1 million in Q1 2022 and bottomed at $5.5 million in Q1 2021.
  • Average Loans and Notes Receivables over 5 years is $25.9 million, with a median of $28.7 million recorded in 2018.
  • The sharpest move saw Loans and Notes Receivables plummeted 65.46% in 2020, then soared 740.29% in 2022.
  • Year by year, Loans and Notes Receivables stood at $28.7 million in 2018, then rose by 27.39% to $36.6 million in 2019, then tumbled by 65.46% to $12.6 million in 2020, then tumbled by 56.53% to $5.5 million in 2021, then skyrocketed by 740.29% to $46.1 million in 2022.
  • Business Quant data shows Loans and Notes Receivables for AHG at $46.1 million in Q1 2022, $5.5 million in Q1 2021, and $12.6 million in Q1 2020.